Product Center
Products Center
Great news! Jiuhua Huayuan Pharmaceutical has been awarded the title of National Specialized, Refined, Unique and New "Little Giant" Enterprise
Release time:
2024-09-18 00:00
Source:
Recently, the Department of Economy and Information Technology of Anhui Province announced the list of the sixth batch of specialized, refined, special and new "little giant" enterprises in Anhui Province. Jiuhua Huayuan Pharmaceutical successfully made the list with outstanding innovation strength and steady development momentum, and was awarded the title of national specialized, refined, special and new "little giant" enterprise.
The selection of "specialized, refined, distinctive and new" enterprises is a process carried out by the Ministry of Industry and Information Technology to thoroughly implement General Secretary Xi Jinping's important instructions on cultivating a group of "specialized, refined, distinctive, and new" small and medium-sized enterprises, and select enterprises with the "four modernizations" characteristics of "specialization, refinement, distinctiveness, and novelty". Emerging from large and comprehensive enterprises, "refined and deep" "little giant" enterprises, as key technology-based enterprises supported by the state, have become the vanguard of enterprise development with their focus on segmented markets, strong innovation capabilities, high market share, mastery of key core technologies, and excellent quality and efficiency. With their high-quality development achievements and good market benefits, they have become the backbone of promoting industrial upgrading and promoting high-quality development of the national economy.
Since its establishment, Jiuhua Huayuan Pharmaceutical has adhered to innovation driven development, steadily promoted research and development innovation, and production technology innovation. It insists on taking plant-based medicine as the core and innovative chemical medicine as the breakthrough, and combines Chinese and Western medicine. Through professional development, refined management, characteristic operation, and technological innovation, it has built the core competitiveness of the enterprise. This selection represents the high recognition of Jiuhua Huayuan Pharmaceutical's technological soft power by national government departments. In the future, the company will take this opportunity to closely follow the national development strategy, adhere to the development concept of "specialization, refinement, novelty", be market-oriented, patient-centered, and committed to providing better medical and health products for society, providing more effective products for patients, making positive contributions to the social health industry, and promoting the steady progress of the modernization process of the medical and health industry.
